Chemed (NYSE:CHE) Stock Rating Upgraded by Zacks Research

Chemed (NYSE:CHEGet Free Report) was upgraded by stock analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a report released on Monday,Zacks.com reports.

Other research analysts have also recently issued research reports about the stock. Jefferies Financial Group cut shares of Chemed from a “buy” rating to a “hold” rating in a report on Thursday, January 22nd. Royal Bank Of Canada upped their target price on shares of Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a report on Monday. Weiss Ratings cut shares of Chemed from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, April 13th. Finally, Oppenheimer lowered their target price on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a report on Friday, February 27th. Two research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Chemed has an average rating of “Hold” and an average price target of $501.50.

Read Our Latest Analysis on Chemed

Chemed Trading Down 0.4%

NYSE CHE opened at $421.19 on Monday. The company has a quick ratio of 0.83, a current ratio of 0.85 and a debt-to-equity ratio of 0.11. Chemed has a 52 week low of $365.20 and a 52 week high of $583.96. The stock has a market capitalization of $6.15 billion, a PE ratio of 22.95, a price-to-earnings-growth ratio of 1.58 and a beta of 0.49. The firm has a 50 day moving average of $401.12 and a two-hundred day moving average of $426.06.

Chemed (NYSE:CHEGet Free Report) last posted its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, topping the consensus estimate of $5.30 by $0.35. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The company had revenue of $657.51 million during the quarter, compared to analysts’ expectations of $659.22 million. During the same quarter in the previous year, the business posted $5.63 EPS. The firm’s revenue was up 1.6% on a year-over-year basis. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. As a group, research analysts expect that Chemed will post 22.31 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $403.18, for a total transaction of $806,360.00. Following the completion of the sale, the chief executive officer owned 93,719 shares in the company, valued at $37,785,626.42. This represents a 2.09% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 3.33% of the stock is currently owned by corporate insiders.

Institutional Trading of Chemed

A number of large investors have recently bought and sold shares of the business. Monetary Solutions Ltd purchased a new position in Chemed during the 4th quarter worth $25,000. Los Angeles Capital Management LLC purchased a new position in Chemed during the 4th quarter worth $26,000. Smartleaf Asset Management LLC raised its position in Chemed by 71.4% during the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after buying an additional 25 shares during the last quarter. BOK Financial Private Wealth Inc. purchased a new position in Chemed during the 4th quarter worth $27,000. Finally, First Horizon Corp purchased a new position in Chemed during the 3rd quarter worth $31,000. Institutional investors and hedge funds own 95.85% of the company’s stock.

About Chemed

(Get Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Featured Stories

Analyst Recommendations for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.